Compare CPNG & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPNG | RVMD |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Durable Goods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.0B | 30.1B |
| IPO Year | 2021 | 2020 |
| Metric | CPNG | RVMD |
|---|---|---|
| Price | $16.68 | $211.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 19 |
| Target Price | $32.00 | ★ $140.84 |
| AVG Volume (30 Days) | ★ 17.4M | 1.6M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.50 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $34,534,000,000.00 | N/A |
| Revenue This Year | $13.15 | N/A |
| Revenue Next Year | $13.75 | $533.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 14.09 | N/A |
| 52 Week Low | $14.92 | $35.64 |
| 52 Week High | $34.08 | $220.34 |
| Indicator | CPNG | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.42 | 67.17 |
| Support Level | $14.97 | $177.04 |
| Resistance Level | $16.92 | N/A |
| Average True Range (ATR) | 0.47 | 6.73 |
| MACD | 0.08 | 0.27 |
| Stochastic Oscillator | 67.73 | 81.90 |
Coupang is South Korea's largest e-commerce platform that sells both owned and third-party inventory. Headquartered in the US, Coupang operates e-commerce businesses mainly in South Korea and Taiwan. The company has built an integrated logistics network that covers the entirety of South Korea, with extensive fulfillment centers that ensure timely delivery, even for orders placed seconds before midnight. Outside of its bread-and-butter e-commerce business, Coupang has expanded into Rocket delivery services to third-party merchants (fulfillment and logistics by Coupang), online grocery delivery Rocket Fresh, online meal delivery (Eats), e-commerce in Taiwan, luxury e-commerce (Farfetch), and travel.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.